Business Context and Reporting Period
Main Street Capital Corporation (MSCC) is an internally managed Business Development Company (BDC) and Small Business Investment Company (SBIC) focused on providing debt and equity financing to lower middle market (LMM) and middle market companies. This Form 10-Q covers the quarterly period ended September 30, 2012.
During the period, MSCC completed the "Final MSC II Exchange," acquiring 100% ownership of Main Street Capital II, LP, eliminating the noncontrolling interest previously associated with that fund. The company also completed a public stock offering in June 2012, raising approximately $93.0 million in net proceeds.
Key Financial Metrics
| Metric | Q3 2012 (Three Months) | YTD 2012 (Nine Months) | YTD 2011 (Nine Months) |
|---|---|---|---|
| Total Investment Income | $22.95 million | $64.36 million | $46.59 million |
| Net Investment Income | $15.52 million | $41.20 million | $27.37 million |
| Net Realized Gain (Loss) | $0.53 million | $5.34 million | $1.70 million |
| Net Change in Unrealized Appreciation | $20.09 million | $40.47 million | $16.78 million |
| Net Increase in Net Assets (Operations) | $31.97 million | $79.96 million | $42.54 million |
| Net Asset Value (NAV) per Share | $17.49 | $17.49 | $14.49 |
| Total Assets | $871.80 million | $871.80 million | $737.69 million (Dec 31, 2011) |
| Total Liabilities | $318.64 million | $318.64 million | $326.50 million (Dec 31, 2011) |
| Cash and Cash Equivalents | $19.58 million | $19.58 million | $42.65 million (Dec 31, 2011) |
| Debt Outstanding (SBIC + Credit Facility) | $297.08 million | $297.08 million | $328.89 million (Dec 31, 2011) |
Note: Debt outstanding includes $194.1 million in SBIC debentures and $103.0 million in Credit Facility borrowings as of September 30, 2012.
Material Changes vs. Prior Period
- Revenue Growth: Total investment income increased 34% in Q3 2012 compared to Q3 2011, driven by higher average levels of portfolio debt investments and increased dividend income. Year-to-date investment income rose 38%.
- Profitability: Net investment income increased 50% in Q3 2012 and 51% YTD 2012 compared to the prior year periods. This was primarily due to portfolio growth, partially offset by higher interest and operating expenses.
- Unrealized Gains: Net change in unrealized appreciation surged 626% in Q3 2012 ($20.1 million vs. $2.8 million) and 141% YTD 2012 ($40.5 million vs. $16.8 million). This was largely attributable to unrealized appreciation on LMM portfolio investments and Middle Market investments.
- Portfolio Composition: The portfolio expanded significantly. LMM investments grew to $467.6 million (fair value) from $415.7 million at year-end 2011. Middle Market investments grew to $350.7 million from $226.5 million.
- Capital Structure: The company expanded its Credit Facility to $287.5 million in July 2012. It also issued $5 million in new SBIC debentures and repaid $16 million in SBIC debentures during the quarter.
Guidance, Outlook, and Risks
Dividends and Distributions: MSCC declared monthly dividends of $0.145 per share for July, August, and September 2012. In November 2012, the company declared a special dividend of $0.35 per share for January 2013 and increased regular monthly dividends to $0.15 per share for Q1 2013, representing an 11.1% increase over Q1 2012.
Recent Developments:
- Laurus Healthcare Exit: In October 2012, MSCC sold the majority of its LMM equity investment in Laurus Healthcare, LP, realizing a gain of approximately $9.9 million.
- Credit Facility Amendment: In November 2012, the Credit Facility was amended to extend the maturity to September 2017 and increase the accordion feature to allow total commitments up to $400 million.
Risks and Contingencies:
- Valuation Risk: Approximately 96% of total assets are portfolio investments valued at fair value. Valuations rely on unobservable inputs (Level 3) for LMM investments, involving significant management judgment regarding EBITDA multiples and discount rates.
- Interest Rate Risk: While most debt investments have fixed rates or floors, the Credit Facility bears floating interest rates. A 1% change in interest rates is not expected to have a material effect on results.
- Economic Conditions: Deterioration in the U.S. economy could impact the ability of portfolio companies to service debt, potentially leading to defaults or increased non-accrual status.
Investor Verification Checklist
- Dividend Sustainability: Verify the composition of dividends (ordinary income vs. return of capital) and the company's ability to maintain the increased dividend rate of $0.15 per share given the mix of cash and non-cash (PIK) income.
- Portfolio Quality: Review the "Investment Rating" distribution. As of Sept 30, 2012, 38.3% of the LMM portfolio was rated "1" (exceeding expectations) and 23.3% rated "2" (above expectations), with only 5.9% rated "4" (underperforming).
- Liquidity Position: Confirm the $19.6 million cash balance and $184.5 million of unused capacity under the Credit Facility are sufficient to fund new investments and cover operating expenses and dividends.
- Realized Gains: Note that the $9.9 million gain on the Laurus Healthcare sale occurred in October 2012 (post-period) and will impact Q4 2012 results, not the reported Q3 figures.
- Debt Covenants: Verify continued compliance with the Credit Facility covenants, specifically the 2.0x interest coverage ratio and 2.5x asset coverage ratio.